Erratum: Expression of concern: “High levels of soluble Major Histocompatibility Complex class I related chain A (MICA) are associated with biliary cast syndrome after liver transplantation” [Transplant Immunology 2009, volume 21, pages 210–214] (High levels of soluble Major Histocompatibility Complex class I related chain A (MICA) are associated with biliary cast syndrome after liver transplantation (2009) 21(4) (210–214), (S0966327409000707), (10.1016/j.trim.2009.06.003));High levels of soluble Major Histocompatibility Complex class I related chain A (MICA) are associated with biliary cast syndrome after liver transplantation

Transplant Immunology

Volumn 21, Issue 4, 2009, Pages 210-214

  Zou, Yizhou ^a   Yang, Xiaoli ^a,b   Jiang, Xiaoxin ^a   Wang, Haiyan ^b   Hao, Qingfang ^b   Liu, Yu ^b   Yu, Ping ^a  

^a The First People s Hospital of Changde City)   (China)

^b General Hospital of Wu Jing   (China)

Author keywords

BCS; Liver transplantation; MICA; NKG2D; Soluble MICA

Indexed keywords

BASILIXIMAB; DACLIZUMAB; GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS 1 RELATED CHAIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILIARY CAST SYNDROME; BILIARY TRACT DISEASE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURGICAL RISK;

EID: 68649083926     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2024.102016     Document Type: Erratum

References (30)

1. Barton P., Maier A., Steininger R., Muhlbacher F., and Lechner G. Biliary sludge after liver transplantation: 1. Imaging findings and efficacy of various imaging procedures. AJR Am J Roentgenol 164 (1995) 859-864
2. Canete J.J., Aidlen J.T., Uknis M.E., and Cicalese L. Images of interest. Hepatobiliary and pancreatic: biliary cast syndrome. J Gastroenterol Hepatol 20 (2005) 791
3. O'Connor H.J., Vickers C.R., Buckels J.A., McMaster P., Neuberger J.M., West R.J., et al. Role of endoscopic retrograde cholangiopancreatography after orthotopic liver transplantation. Gut 32 (1991) 419-423
4. Sheng R., Ramirez C.B., Zajko A.B., and Campbell W.L. Biliary stones and sludge in liver transplant patients: a 13-year experience. Radiology 198 (1996) 243-247
5. Gor N.V., Levy R.M., Ahn J., Kogan D., Dodson S.F., and Cohen S.M. Biliary cast syndrome following liver transplantation: predictive factors and clinical outcomes. Liver Transpl 14 10 (2008) 1466-1472
6. Waldram R., Williams R., and Calne R.Y. Bile composition and bile cast formation after transplantation of the liver in man. Transplantation 19 (1975) 382-397
7. Barton P., Maier A., Steininger R., Muhlbacher F., and Lechner G. Biliary sludge after liver transplantation: 2. Treatment with interventional techniques versus surgery and/or oral chemolysis. AJR Am J Roentgenol 164 (1995) 865-869
8. Barton P., Maier A., Steininger R., et al. Biliary sludge after liver transplantation: 1) Imaging findings and efficacy of various imaging procedures. AJR Am J Roentgenol 164 (1955) 859-864
9. Parry S.D., and Muiesan P. Cholangiopathy and the biliary cast syndrome. Eur J Gastroenterol Hepatol 15 (2003) 341-343
10. Shah J.N., Haigh W.G., Lee S.P., Lucey M.R., Brensinger C.M., Kochman M.L., et al. Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol 98 (2003) 1861-1867
11. Bak S.H., Choi H.S., Yang S.Y., Jun D.W., Han S.H., Lee H.L., et al. Obstructive jaundice due to biliary cast syndrome followed by orthotopic liver transplantation. Korean J Gastroenterol 48 (2006) 119-123
12. Starzl T.E., Putnam C.W., Hansbrough J.F., Porter K.A., and Reid H.A. Biliary complications after liver transplantation with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery 81 (1977) 212-221
13. Chan S.C., Lo C.M., Liu C.L., and Fan S.T. Resurgence of biliary cast syndrome. Liver Transpl 11 (2005) 242-243
14. Tieng V., Le Bouguénec C., du Merle L., Bertheau P., Desreumaux P., Janin A., Charron D., et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A 99 5 (2002) 2977-2982
15. Groh V., Wu J., Yee C., and Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419 6908 (2002) 734-738
16. Quiroga I., Salio M., Koo D.D., Cerundolo L., Shepherd D., Cerundolo V., et al. Expression of MHC class I-related chain B (MICB) molecules on renal transplant biopsies. Transplantation 81 8 (2006) 1196-1203
17. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285 5428 (1999) 730-732
18. Ogasawara K., and Lanier L.L. NKG2D in NK an T cell-mediated immunity. J Clin Immunol 25 (2005) 534-540
19. Salih H.R., Rammensee H.G., and Steinle A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169 8 (2002) 4098-4102
20. Kohga K., Takehara T., Tatsumi T., Ohkawa K., Miyagi T., Hiramatsu N., et al. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci 99 8 (2008) 1643-1649
21. Salih H.R., Rammensee H.G., and Steinle A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169 8 (2002) 4098-4102
22. Zou Y., Heinemann F.M., Grosse-Wilde H., Sireci G., Wang Z., Lavingia B., et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 67 (2006) 230-237
23. Zou Y., and Stastny P. Alternatively spliced forms of MICA and MICB lacking exon 3 in a human cell line and evidence of presence of similar RNA in human peripheral blood mononuclear cells. Immunogenetics 54 9 (2002) 671-674
24. Kapan E.L., and Meire P. Nonparametric estimation from incomplete observations. J Am Sta Assoc 53 (1958) 457-481
25. Suárez-Alvarez B., López-Vázquez A., Díaz-Molina B., Bernardo-Rodríguez M.J., Alvarez-López R., Pascual D., et al. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection. Transplantation 82 3 (2006) 354-361
26. Uzunel M., Kasimu H., Joshi M., Ge X., Liu J., Xu B., et al. Evidence for no relevance of anti-major histocompatibility complex class I-related chain a antibodies in liver transplantation. Liver Transpl 14 12 (2008) 1793-1802
27. Jinushi M., Takehara T., Tatsumi T., Hiramatsu N., Sakamori R., Yamaguchi S., et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 43 6 (2005) 1013-1020
28. Patel R., Badley A.D., Larson-Keller J., Harmsen W.S., Ilstrup D.M., Wiesner R.H., et al. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 61 8 (1996) 1192-1197
29. Halme L., Hockerstedt K., and Lautenschlager I. Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 75 11 (2003) 1853-1858
30. Park J.B., Kwon C.H., Choi G.S., Chun J.M., Jung G.O., Kim S.J., et al. Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. Transplantation 86 11 (2008) 1536-1542